2025
SJR Q1
JCR Q1 · 60,7
SCIE
Journal detail
Nature Reviews Cancer
- Publisher
- Nature Research
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
1474175X14741768
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 22,814
- Quartile Q1
- H-Index 548
- Cites/doc 25,8
- Docs (3y) 335
- Cites (3y) 9.851
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 60,7
- 5Y JIF 85
- JCI 7,66
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q1
- Oncology Q1
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 22,814 | 60,7 | 85 | 7,66 | Q1 | 548 |
| 2024 | Q1 | Q1 | 24,378 | 66,8 | 81 | 9,04 | Q1 | 527 |
| 2023 | Q1 | Q1 | 26,837 | 72,5 | 77,2 | 9,95 | Q1 | 527 |
| 2022 | Q1 | Q1 | 20,977 | 78,5 | 80,3 | 8,86 | Q1 | 527 |
| 2021 | Q1 | Q1 | 16,955 | 69,8 | 79 | 7,95 | Q1 | 527 |
| 2020 | Q1 | Q1 | 19,575 | 60,7 | 68,8 | 7,64 | Q1 | 527 |
| 2019 | Q1 | Q1 | 21,287 | 53 | 52,7 | 8,08 | Q1 | 527 |
| 2018 | — | Q1 | — | 51,8 | 50,5 | 8,02 | Q1 | — |
| 2017 | Q1 | Q1 | 23,53 | 42,8 | 50,3 | 6,8 | Q1 | 527 |
| 2016 | Q1 | Q1 | 22,315 | 37,1 | 47,9 | — | — | 527 |
| 2015 | Q1 | Q1 | 25,056 | 34,2 | 42,3 | — | — | 527 |
| 2014 | Q1 | Q1 | 24,923 | 37,4 | 44,3 | — | — | 527 |
| 2013 | Q1 | Q1 | 17,819 | 37,9 | 41,7 | — | — | 527 |
| 2012 | Q1 | Q1 | 14,061 | 35 | 39,4 | — | — | 527 |
| 2011 | Q1 | Q1 | 12,006 | 37,5 | 38,5 | — | — | 527 |
| 2010 | Q1 | Q1 | 11,332 | 37,2 | 37,9 | — | — | 527 |
| 2009 | — | Q1 | — | 29,5 | 35 | — | — | — |
| 2008 | — | Q1 | — | 30,8 | 35 | — | — | — |
| 2007 | — | Q1 | — | 29,2 | 37,2 | — | — | — |
| 2006 | — | Q1 | — | 31,6 | — | — | — | — |
| 2005 | — | Q1 | — | 31,7 | — | — | — | — |
| 2004 | — | Q1 | — | 36,6 | — | — | — | — |
| 2003 | — | Q1 | — | 34 | — | — | — | — |
| 2002 | — | Q1 | — | 13,6 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | SCIE | Q1 | Q1 | 4/333 |
| 2024 | ONCOLOGY | SCIE | Q1 | Q1 | 3/328 |
| 2023 | ONCOLOGY | SCIE | Q1 | Q1 | 3/322 |
| 2022 | ONCOLOGY | SCIE | Q1 | Q1 | 3/241 |
| 2021 | ONCOLOGY | SCIE | Q1 | Q1 | 2/245 |
| 2020 | ONCOLOGY | SCIE | Q1 | Q1 | 3/242 |
| 2019 | ONCOLOGY | SCIE | Q1 | Q1 | 3/244 |
| 2018 | ONCOLOGY | SCIE | Q1 | Q1 | 2/230 |
| 2017 | ONCOLOGY | SCIE | Q1 | Q1 | 2/223 |
| 2016 | ONCOLOGY | SCIE | Q1 | — | 2/217 |
| 2015 | ONCOLOGY | SCIE | Q1 | — | 2/213 |
| 2014 | ONCOLOGY | SCIE | Q1 | — | 2/211 |
| 2013 | ONCOLOGY | SCIE | Q1 | — | 2/203 |
| 2012 | ONCOLOGY | SCIE | Q1 | — | 2/197 |
| 2011 | ONCOLOGY | SCIE | Q1 | — | 2/196 |
| 2010 | ONCOLOGY | SCIE | Q1 | — | 2/185 |
| 2009 | ONCOLOGY | SCIE | Q1 | — | 2/166 |
| 2008 | ONCOLOGY | SCIE | Q1 | — | 2/143 |
| 2007 | ONCOLOGY | SCIE | Q1 | — | 2/132 |
| 2006 | ONCOLOGY | SCIE | Q1 | — | 2/127 |
| 2005 | ONCOLOGY | SCIE | Q1 | — | 2/123 |
| 2004 | ONCOLOGY | SCIE | Q1 | — | 2/123 |
| 2003 | ONCOLOGY | SCIE | Q1 | — | 1/120 |
| 2002 | ONCOLOGY | SCIE | Q1 | — | 3/114 |